Hrt Financial LP Ocular Therapeutix, Inc Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$4.6 - $7.64 $250,055 - $415,310	54,360 New	54,360 $280,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $44,450 - $70,642	10,868 New	10,868 $45,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $31,213 - $54,131	-10,370 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $50,087 - $76,219	10,370 New	10,370 $51,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $441,893 - $865,853	-71,736 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $303,910 - $449,286	31,331 Added 77.54%	71,736 $717,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $542,639 - $774,159	40,405 New	40,405 $572,000
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $88,315 - $256,236	-11,165 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$7.36 - $9.87 $82,174 - $110,198	11,165 New	11,165 $84,000
Q1 2020 May 15, 2020	SELL	$3.95 - $7.4 $78,210 - $146,520	-19,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.73 $50,886 - $93,654	19,800 New	19,800 $78,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $673M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.